The Society
More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community
Become an ERS member
Registration is open for the next edition of ERS Vision Live – our live panel discussion series hosted on the ERS Respiratory Channel. The event focuses on the improvement of personalised biological treatment of asthma and COPD.
The expert panellists will be discussing key areas and addressing questions, such as:
The event is completely free to access but registration is required.
Guy Brusselle is Professor and Head of the Department of Respiratory Medicine at Ghent University Hospital, Ghent, Belgium. His research areas of interest are asthma and severe asthma, encompassing clinical research, translational research and epidemiologic research. He served as ERS Guidelines Director from 2012-2016 and ERS Science Council Chair from 2016-2019.
Celeste Porsbjerg is Professor of Severe Asthma at the Department of Respiratory Medicine, Bispebjerg Hospital, Copenhagen, where she heads the severe asthma clinic and chairs the Respiratory Research Unit. Her research revolves around solving key clinical issues in difficult asthma, understanding disease mechanisms, and personalising asthma management. She chairs the Danish Severe Asthma Registry (DSAR), and the NORDSTAR Asthma Research Consortium, and is the national representative for Denmark in the SHARP ERS Clinical Research Collaboration and ISAR.
Arnaud Bourdin is a Professor at the Department of Respiratory Medicine in Montpellier, France. He is head of the research team in INSERM unit 1046, a GINA advocate and a Fellow of the ERS. Prof. Bourdin's main research interests are within severe asthma and COPD.
Anneke ten Brinke is Head of the Severe Asthma Center at Medical Center Leeuwarden, Leeuwarden, the Netherlands. Her research focuses on severe asthma, with a particular emphasis on phenotyping, pathophysiological mechanisms, monitoring, and therapeutic approaches. Prof. ten Brinke also chairs the Dutch Severe Asthma Registry and is a Fellow of the ERS.
Dr. Nair is the Frederick E. Hargreave Teva Innovation Chair in Airway Diseases & Professor of Medicine in the Division of Respirology at McMaster University in Hamilton, Ontario, Canada. He provides tertiary care to patients with severe asthma and other complex airway and eosinophilic lung diseases. He directs a patient-centred translational research program at the Firestone Institute of St Joseph’s Healthcare, focused on charactering bronchitis using sputum biomarkers and targeted therapy with biologics and small molecule antagonists.
Johann Christian Virchow is a full Professor of Medicine, he is also Head of the departments of respiratory medicine (pneumology) and intensive care medicine at the Universitätsmedizin in Rostock, Germany. Prof. Virchow's research interest and publications centre around chronic airway inflammation, especially asthma and its treatment.